Leef Brands Inc. (LEEEF): Cost of Revenue

Annual figures by period end, from SEC filings.

$24.30M
Year ended 2025-12-31
$19.40M
Trailing 12 months to 2026-06-30
2024-12-31: $20.81M2025-12-31: $24.30M$24.30M
2024-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$24.30M+16.8%2026-03-26, From 2025-01-01
2024-12-31$20.81Mn/a2026-03-26, From 2024-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Leef Brands Inc. (LEEEF)2025-12-31$24.30M+16.8%
C21 Investments Inc. (CWLXF)2026-03-31$19.01M+8.3%
Synergy CHC Corp. (SNYRQ)2025-12-31$10.08M-9.9%
Cyanotech Corp (CYAN)2025-03-31$17.34M+1.2%
Charlie's Holdings, Inc. (CHUC)2025-12-31$15.26M+212.2%
Bon Natural Life Ltd (BON)2025-09-30$14.79M-11.6%
Fitlife Brands, Inc. (FTLF)2025-12-31$50.01M+37.4%
Mannatech Inc (MTEX)2025-12-31$27.08M+2.5%
Niagen Bioscience, Inc. (NAGE)2025-12-31$46.23M+21.6%

Compare LEEEF, CWLXF, SNYRQ, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗